[2Q20 VS. 1Q20] [2Q20 VS. 2Q 19] FX: THB/USD 31.6345 31.1053 31.3450 Sales Revenue, THB 2,127.5 3,259.7 -34.7% 2,992.8 -28.9% [ Sales Revenue, USD $67.2 $104.8 -35.8% $95.5 -29.6% ] Cost of Sales 1,740.9
11,672.35 399.51 3.4 Total cost and expenses * 2,141.33 2,107.37 33.96 1.6 6,664.32 6,201.44 462.88 7.5 Loss on foreign exchange (163.48) (31.66) (131.82) (416.4) (349.13) (550.55) 201.42 36.6 Profit
, which was adjusted upward from the 4.3%, due to the stronger growth during 1H/2018. The key drivers were the export and tourism, whereby the local expenditure was driven by household consumption and
Assets. As a result, the Company is required to disclose the information memorandum on entering into such transaction to the Stock Exchange of Thailand (the “SET”) and to send a circular letter to the
cost) 2,135.19 1,588.22 546.97 34.4 Revenue from finance lease contract 738.69 853.62 (114.93) (13.5) Share of profit of associates / joint ventures 1,281.83 1,727.16 (445.33) (25.8) Other incomes 232.17
three year comparison Analytical explanation of: Financial status (assets, liquidity, capital expenditure, sources of capital (debt / equity)) Performance (income and equity of business, expenditure
properties and cost management In 1Q18, the Thai economy continues to expand, primarily driven by a number of supporting factors, namely 1) growth in exports with a record high in March 2018. 2) Growth in the
, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of
238.99 261.84 (22.85) (8.73) Other income 9.49 13.06 (3.57) (27.34) Total revenues 248.48 274.90 (26.42) (9.61) Cost of goods sold 139.89 151.91 (12.02) (7.91) Selling expenses and administrative expenses
VS. 2017] FX: THB/USD 30.7810 32.0754 33.7691 FX: THB/EUR 34.2753 37.7340 37.7119 Sales Revenue 12,097.4 13,982.5 -13.5% 14,195.4 -1.5% [ Sales Revenue, USD $393.0 $435.9 -9.8% $420.4 +3.7% ] Cost of